These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 27379248)

  • 1. The Preclinical Research Progress of Stem Cells Therapy in Parkinson's Disease.
    Zhang J; Wang X; Li J; Huang R; Yu X; Dong C; Liu P; Zhang F; Hu J; Qi Y; Zhang J; Li Q; Yan B
    Biomed Res Int; 2016; 2016():5683097. PubMed ID: 27379248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress in Dopaminergic Cell Replacement and Regenerative Strategies for Parkinson's Disease.
    Chen W; Huang Q; Ma S; Li M
    ACS Chem Neurosci; 2019 Feb; 10(2):839-851. PubMed ID: 30346716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell therapy for Parkinson's disease: Functional role of the host immune response on survival and differentiation of dopaminergic neuroblasts.
    Wenker SD; Leal MC; Farías MI; Zeng X; Pitossi FJ
    Brain Res; 2016 May; 1638(Pt A):15-29. PubMed ID: 26239914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Olfactory mucosa is a potential source for autologous stem cell therapy for Parkinson's disease.
    Murrell W; Wetzig A; Donnellan M; Féron F; Burne T; Meedeniya A; Kesby J; Bianco J; Perry C; Silburn P; Mackay-Sim A
    Stem Cells; 2008 Aug; 26(8):2183-92. PubMed ID: 18535154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
    During MJ; Kaplitt MG; Stern MB; Eidelberg D
    Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Parkinson syndrome and cognitive disorders].
    Szirmai I; Kovács T
    Ideggyogy Sz; 2002 Jul; 55(7-8):220-5. PubMed ID: 12201229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell transplantation for Parkinson's disease: present status.
    Drucker-Colín R; Verdugo-Díaz L
    Cell Mol Neurobiol; 2004 Jun; 24(3):301-16. PubMed ID: 15206816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic potentials of human adipose-derived stem cells on the mouse model of Parkinson's disease.
    Choi HS; Kim HJ; Oh JH; Park HG; Ra JC; Chang KA; Suh YH
    Neurobiol Aging; 2015 Oct; 36(10):2885-92. PubMed ID: 26242706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local field potential beta activity in the subthalamic nucleus of patients with Parkinson's disease is associated with improvements in bradykinesia after dopamine and deep brain stimulation.
    Ray NJ; Jenkinson N; Wang S; Holland P; Brittain JS; Joint C; Stein JF; Aziz T
    Exp Neurol; 2008 Sep; 213(1):108-13. PubMed ID: 18619592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stem cell therapy for Parkinson's disease using non-human primate models.
    Chen ZZ; Niu YY
    Zool Res; 2019 Sep; 40(5):349-357. PubMed ID: 31343853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of stem cells in Parkinson's disease.
    Gupta A; Dawson TM
    Neurosurg Clin N Am; 2007 Jan; 18(1):129-42, x-xi. PubMed ID: 17244560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroimaging for optimization of stem cell therapy in Parkinson's disease.
    Hayashi T; Onoe H
    Expert Opin Biol Ther; 2013 Dec; 13(12):1631-8. PubMed ID: 24206114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cell therapy for Parkinson's disease: I. Embryonic and adult donor tissue transplantation].
    Anisimov SV
    Adv Gerontol; 2008; 21(4):575-92. PubMed ID: 19432209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toward full restoration of synaptic and terminal function of the dopaminergic system in Parkinson's disease by stem cells.
    Isacson O; Bjorklund LM; Schumacher JM
    Ann Neurol; 2003; 53 Suppl 3():S135-46; discussion S146-8. PubMed ID: 12666105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stem cell-based therapy for Parkinson's disease.
    Correia AS; Anisimov SV; Li JY; Brundin P
    Ann Med; 2005; 37(7):487-98. PubMed ID: 16278162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in stem-cell--generated transplantation therapy for Parkinson's disease.
    Sundberg M; Isacson O
    Expert Opin Biol Ther; 2014 Apr; 14(4):437-53. PubMed ID: 24437368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-based therapies for Parkinson's disease.
    Dyson SC; Barker RA
    Expert Rev Neurother; 2011 Jun; 11(6):831-44. PubMed ID: 21651331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parkinson's disease: from genetics to treatments.
    Fan HC; Chen SJ; Harn HJ; Lin SZ
    Cell Transplant; 2013; 22(4):639-52. PubMed ID: 23127617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stem cell therapy for Parkinson's disease: where do we stand?
    Roybon L; Christophersen NS; Brundin P; Li JY
    Cell Tissue Res; 2004 Oct; 318(1):261-73. PubMed ID: 15309619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell replacement therapy for Parkinson's disease.
    Wijeyekoon R; Barker RA
    Biochim Biophys Acta; 2009 Jul; 1792(7):688-702. PubMed ID: 19007882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.